Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.

About Us


  • NYOH Announces Monthly Breast Cancer Survivorship Series


    We've concluded our 2021 monthly fireside chats. Stay tuned for our 2022 series. NYOH partnered with breast health and medical experts across the east coast to host monthly programming focused on breast health, cancer and survivorship. Dr. Maria Theodoulou, Program Director, Breast Medicine Services at New York Oncology Hematology and Dr.... Read More

  • NYOH Recognized by Highmark Blue Shield of Northeastern NY for its Quality in Value-Based Cancer Care


    NYOH recently received designation by Highmark Blue Shield of Northeastern NY (NENY) as a Blue Distinction® Center for Cancer Care, which is part of the Blue Distinction Specialty Care program. By combining nationally consistent quality criteria with locally effective value-based programs, Blue Distinction Centers for Cancer Care deliver maximum value to members battling cancer by aligning health care payments... Read More

  • Spring to Life 2021: Conference on Leukemias


    May 14 & 15, 2021 CME-Accredited Online LIVE Broadcast Conference ABOUT THE CONFERENCE New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, the Leukemia & Lymphoma Society and a... Read More

  • MYLUNG to deepen understanding of barriers and address challenges to improve care for lung cancer patients, including those with targetable mutations


    New York Oncology Hematology (NYOH) recently joined the MYLUNG consortium, a large-scale community-based research study to advance precision medicine options for non-small cell lung cancer (NSCLC) patients. NSCLC is the most common type of lung cancer according to the American Cancer Society, accounting for about 84% of lung cancer cases. The MYLUNG consortium – or “Molecularly Informed Lung Cancer Treatment... Read More

  • Dr. Todd Doyle Elected as New York Oncology Hematology Practice President


    Region’s Largest Cancer Provider Welcomes Well-Renowned Radiation Oncologist to Lead the Practice New York Oncology Hematology (NYOH) recently announced that its board of directors elected Dr. Todd Doyle to serve as the next practice president. Dr. Doyle, a radiation oncologist at NYOH, has served on the practice’s board of directors for ten years and currently serves... Read More

  • Susan G. Komen Northeastern NY names Colleen Murray 2020 Hope Award Recipient


    Congratulations to NYOH's Colleen Murray, FNP-C, RNFA, who was honored on November 1, 2020 at the Annual Susan G. Komen Northeastern New York Pink Ribbon (Virtual) Luncheon as the 2020 Hope Award recipient. The Hope Award "recognizes a breast care professional who improves the lives of breast cancer patients."   Murray received the Hope Award for her commitment to her patients... Read More

  • Dr. Olds on importance of mammograms


    NYOH's Tia Olds, MD, a radiation oncologist kicks off breast cancer awareness month by discussing the importance of scheduling mammograms.  Olds says that because of COVID, many patients have postponed or skipped cancer screenings. The National Cancer Institute (NCI) warns that modeling suggests nearly 10,000 excess deaths from breast and colorectal cancer over the next decade, due to delays... Read More

  • Join NYOH at Free Lung Cancer Event on Saturday, October 10th at 2pm


    All NYOH patients are invited to "Breathing Space: Community Dialogues on Living with Lung Cancer." This free event is part of the 7th annual Spring to Life, an annual cancer conference. The event is open to patients, survivors, families and caregivers and will include resources and opportunities for those living with lung cancer.  Those who sign up will receive... Read More

  • Welcome, Dr. George


    New York Oncology Hematology, the region’s largest provider of cancer and blood disorder care, is pleased to announce Reju Mathew George, M.D. has joined our team of medical oncologists and hematologists.  Dr. George comes to us upon completion of his Fellowship in Hematology & Oncology at Baystate Medical Center in Springfield, MA. He... Read More

  • NYOH plays role in new drug test to detect cancer


    Amy Zuchelkowski, Director of Research Operations, talks with WNYT's Benita Zahn about a new clinical trial that tests for 50 cancers. NYOH participated in a trial that was a precursor to Pathfinder, with Dr. Lawrence Garbo as Principal Investigator.  NYOH offers the region's largest clinical research operation, participating in more than 500 drug trials over... Read More

  • Next Page